Valuation dashboard for GeoVax Labs, Inc. (GOVX) with P/E N/A, P/B 1.05, EV/EBITDA -0.09 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform.
Analysis Summary
GeoVax Labs, Inc. reported revenue of $2.5M in the most recent fiscal year, growing at a 5-year CAGR of 6.4%.
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $0.41, GOVX has negative trailing earnings (P/E not meaningful) and an ROE of -5.61%. Market capitalisation stands at $3M.
Balance sheet quality for GOVX: current ratio of 2.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.05 |
| EV / EBITDA | -0.09 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $0.49 |
| vs Current Price | +20.5% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| GOVX | GeoVax Labs, Inc. | $3M | 1.05 | -5.6% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $0.41 |
| Market Cap | $3M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -561.15% |
| Return on Invested Capital | -463.53% |
| Return on Assets | -338.46% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ADAP · ADTX · AIMD · ANL · APLM · BLRX · ICU
Explore sector: Healthcare · Biotechnology
More sections of GOVX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks